BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36991117)

  • 21. Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.
    Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
    Int J Oncol; 2016 Aug; 49(2):700-8. PubMed ID: 27279345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranilast Inhibits TGF-β1-induced Epithelial-mesenchymal Transition and Invasion/Metastasis
    Takahashi K; Menju T; Nishikawa S; Miyata R; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Date H
    Anticancer Res; 2020 Jun; 40(6):3287-3296. PubMed ID: 32487624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Shan B
    Mol Biol Rep; 2012 Oct; 39(10):9453-62. PubMed ID: 22722999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol promotes alcohol-related colorectal cancer metastasis via the TGF-β/RUNX3/Snail axis by inducing TGF-β1 upregulation and RUNX3 cytoplasmic mislocalization.
    Zheng K; Yu J; Chen Z; Zhou R; Lin C; Zhang Y; Huang Z; Yu L; Zhao L; Wang Q
    EBioMedicine; 2019 Dec; 50():224-237. PubMed ID: 31757777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC.
    Li H; Wang S; Li X; Weng Y; Guo D; Kong P; Cheng C; Wang Y; Zhang L; Cheng X; Cui Y
    Cancer Sci; 2023 Jan; 114(1):91-104. PubMed ID: 36056599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4.
    Wang Z; Chen J; Wang S; Sun Z; Lei Z; Zhang HT; Huang J
    Cell Death Dis; 2022 Jul; 13(7):656. PubMed ID: 35902557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer.
    Chan MW; Huang YW; Hartman-Frey C; Kuo CT; Deatherage D; Qin H; Cheng AS; Yan PS; Davuluri RV; Huang TH; Nephew KP; Lin HJ
    Neoplasia; 2008 Sep; 10(9):908-19. PubMed ID: 18714391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5.
    Tabata T; Kokura K; Ten Dijke P; Ishii S
    Genes Cells; 2009 Jan; 14(1):17-28. PubMed ID: 19032343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
    Yuki R
    Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
    Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
    Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.
    Azmi PB; Seth AK
    Anticancer Res; 2009 Jun; 29(6):2253-63. PubMed ID: 19528490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.